Keywords

• Voglibose
• Basen
• 83480-29-9

Quick Details

• ProName: Manufacturer of Voglibose at Factory P...
• CasNo: 83480-29-9
• Molecular Formula: C10H21NO7
• Appearance: Colourless Crystalline Solid
• Application: Pharmaceutical Material
• DeliveryTime: Within 3 days after payment confirmed
• PackAge: 25kg/fiber drum
• Port: Any port in China
• ProductionCapacity: 1,000 Metric Ton/Year
• Purity: 99%
• Transportation: By sea
• LimitNum: 25 Kilogram
• Related Substances: Voglibose
• Residue on Ignition: 0.3Max
• Heavy Metal: <10ppm
• Valid Period: 2 years
• Voglibose: 83480-29-9

Superiority

1. We are one of the domestic largest manufacturers of API;

2. We are always supplier of products with higher quality and at more competitive price;

3. We are supplier of safe and ecofriendly products ;

4. We provide stable supply and efficient service;

5. Delivery in time;

6. Cooperate with scientific research institutions to keep the leading position on the field of technology.

7. We can provide products to all customers all over the world.

Details

Voglibose Basic information

Product Name: Voglibose
Synonyms: VOGLIBOSE;3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPIINOSITOL;3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL;5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol;VOGLIBOSE, 99+%;A 71100;AO 128;Basen
CAS: 83480-29-9
MF: C10H21NO7
MW: 267.28
EINECS: 
Product Categories: Miscellaneous;VOGLIBOSE;All Inhibitors;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;Carbohydrates & Derivatives;Diabetes Research
Mol File: 83480-29-9.mol

Voglibose Usage And Synthesis

Chemical Properties Colourless Crystalline Solid
Usage An alpha-Glucosidase inhibitor used as an antidiabetic
Usage An α-Glucosidase inhibitor used as an antidiabetic.
Usage For the treatment of diabetes. It is specifically used for lowering post-prandial blood glucose levels thereby reducing the risk of macrovascular complications.
Biological Activity Orally active α -glucosidase inhibitor (IC 50 values are 3.9 and 6.4 nM at sucrase and maltase respectively). Increases glucagon-like peptide 1 (GLP-1) secretion and decreases food consumption in ob/ob mice, and reduces plasma concentrations of glucose, triglycerides and insulin in Wistar fatty rats. Exhibits antidiabetic and antiobesity activity in vivo .